Sino Biopharmaceutical | 1177 - Cost Of Sales


Sino Biopharmaceutical reported CNY3.08B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Jiangsu Hengrui CNY 1.02B 68.56M Jun/2026
Moderna USD 93M 862M Jun/2026
Organon & Co USD 711M 34M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026